Shared care guidelines
Below you can find all of the shared care guidelines approved for use across the North East and North Cumbria ICS.
For legacy shared care guidelines, you may still need to visit the previous APC websites until a single NENC ICB version is available.
NTAG workplan includes the review of shared care clinical protocols across NENC ICS. Due to historical arrangements shared care clinical protocols differ geographically. Following review by NTAG, these new ICS wide approved clinical protocols are now being published to ensure clinical information is correct and up to date. NTAG is aware that there is an ongoing LIS/LES review (Local Incentive Scheme and Local Enhanced Service) within the ICB that is reviewing the remuneration to GP practices for undertaking shared care across the ICS.
| Title | Documents | Decision | Date | |
|---|---|---|---|---|
| NENC Shared Care Protocol - Amiodarone for patients in adult services | NENC SCP - amiodarone - v2.0 - approved Feb 2024 | Approved by NENC Medicines Subcommittee | 12/02/2024 | |
| NENC Shared Care Protocol - Apomorphine injection for patients within adult services with Parkinson's disease | NENC SCG - apomorphine injection in parkinson - v1.0 - approved Dec 2024 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 12/12/2024 | |
| NENC Shared Care Protocol - Azathioprine and mercaptopurine within adult services (non-transplant indications) | NENC SCG azathioprine mercaptopurine in adults for non-transplant indications - v1.0 - approved Dec 2024 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 12/12/2024 | |
|
New 07/05/2025 |
NENC Shared Care Protocol - Denosumab for primary and secondary prevention of fracture in women and men over the age of 50 | NENC SCP - Denosumab for primary and secondary prevention of fracture - v1.0 - approved April 2025 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 10/04/2025 |
| NENC Shared Care Protocol - Dronedarone for patients in adult services | NENC SCP - dronedarone - v2.0 - approved Feb 2024 | Approved by NENC Medicines Subcommittee | 12/02/2024 | |
| NENC Shared Care Protocol - Hydroxychloroquine for patients within adult services | NENC SCP - hydroxychloroquine - v1.1 - approved Feb 2025 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 13/02/2025 | |
| NENC Shared Care Protocol - Leflunomide for patients within adult services | NENC SCP -Leflunomide for patients within adult services- v1.0 - approved Feb 2025 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 13/02/2025 | |
| NENC Shared Care Protocol - Lithium for adult patients within mental health services | NENC-SCP-lithium-in-adults - v1.0 - approved Feb 2025 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 13/02/2025 | |
| NENC Shared Care Protocol - Mycophenolate mofetil and mycophenolic acid in adults (non-transplant indications) | NENC SCP mycophenolate mofetil mycophenolic acid in adults non-transplant indications v1.0 - approved Feb 2025 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 13/02/2025 | |
| NENC Shared Care Protocol - Riluzole for patients in adult services | NENC SCP - riluzole - v1.0 - approved Feb 2024 | Approved by NENC Medicines Subcommittee | 12/02/2024 | |
| NENC Shared Care Protocol - Sativex for the treatment of spasticity in multiple sclerosis - June 2023 | NENC Shared Care Protocol - Sativex for the treatment of spasticity in multiple sclerosis - June 2023 | Approved by NENC Medicines Subcommittee | 20/06/2023 | |
| NENC Shared Care Protocol - Sulfasalazine for patients within adult services | NENC SCP - Sulfasalazine for patients within adult services- v1.0 - approved Feb 2025 | Approved by NENC Clinical Effectiveness and Governance (CEG) Subcommittee | 13/02/2025 |